Primary screening

High Throughput in living cells

Fluofarma can perform for its customers, large scale primary screening in living cells to select the best hits among thousand of compounds. Thanks to Fluofarma High Content Screening technology, you will able to use functional analysis during all your drug discovery process.

► 2000 wells tested per days with 2500 cells analyzed per wells

Flexibles services

Fluofarma developed a flexible approach to drug discovery tailored to your specific needs. Fluofarma manages programs for any kinds of compounds as chemical entities, crude extracts, gene collections, proteins…

Fluofarma creative team of scientists will help you design the perfect assays.

More than 130 cell-based assays for focused screening
Design of customized assays

Expertise

Fluofarma scientists acquired a strong expertise in molecular and cell biology which can help you to improve your drug discovery process.

 

Breaking news

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal Cell Research.

    Read more [+]

  • Publication

    Fluofarma cited in a Biocompare featured article “Flow Cytometry Gets a Makeover”

    Read more [+]

  • Press Release

    Roche adopts Fluofarma’s high-content screening platform.

    Read more [+]

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal "Analytical Chemistry".

    Read more [+]

Roche adopts Fluofarma’s platform
October 19, 2009 – Fluofarma announced today that it entered into a multi-year agreement with Roche.
Read More



ALL NEWS